Table 3 Initial treatment and angiographic characteristics
STEMI (n = 101) | NSTEMI (n = 490) | |
|---|---|---|
Initial management | ||
Primary MICU involvement | 79 (78.2) | – |
Initial remote ED admission and immediate MICU transfera | 22 (21.8) | – |
Medication before arrival in the cath-lab | ||
Aspirin | 95 (94.1) | 473 (96.5) |
Clopidogrel | 63 (62.4) | 310 (63.3) |
Prasugrel | 14 (13.9) | 10 (2.0) |
Ticagrelor | 24 (23.8) | 170 (34.7) |
Unfractionated heparin | 15 (14.9) | 191 (39.0) |
Low-molecular-weight heparin | 71 (70.3) | 292 (59.6) |
Bivalirudin | 15 (14.9) | 7 (1.4) |
GP IIb/IIIa inhibitor | 30 (29.7) | 98 (20.0) |
Interventional characteristics | ||
Characteristics of CAD | ||
Single-vessel disease | 69 (68.3) | 258 (52.7) |
Two-vessel disease | 25 (24.8) | 119 (24.3) |
Three-vessel disease | 7 (6.9) | 57 (11.6) |
No significant CAD | 0 | 56 (11.4) |
Emergency primary coronary angiogram | 43 (42.6) | |
(Primary) PCI | 33/43 (76.7) | 274/490 (55.9) |
Fibrinolysis | 58 (57.4) | |
Rescue coronary angiogram after fibrinolysis | 27 (26.7) | |
Rescue PCI after fibrinolysis | 20/27 (74.1) | |
Delayed coronary angiogram after fibrinolysis | 31 (30.7) | |
Delayed PCI after fibrinolysis | 29/31 (93.5) | |
Delayed bypass | 2 (2.0) | 26 (5.3) |
Medical treatment only (no PCI or CABG) | 17 (16.8) | 190 (38.8) |
Stent implantation | 75 (74.3) | 250 (51.0) |
Balloon only (no stent) | 7 (6.9) | 24 (4.9) |